21st WRIB Highlights

Full Immersion in Bioanalysis
  • Small & Large Molecules
  • Biomarkers
  • Immunogenicity
  • Gene/Cell Therapy
  • Vaccine Assays
  • Critical Reagents
  • Peptide & Oligos
  • New Modalities
  • LBA, Flow Cytometry
  • PCR, ELISpot, NGS
  • LC-MS/MS & HRMS
  • Hybrid LBA/LCMS
  • Emerging Technologies
Hear from Regulators...
  • US FDA
  • EU EMA
  • UK MHRA
  • Health Canada
  • Brazil ANVISA
  • Austria AGES
  • Belgium FAMHP
  • Italy AIFA
Learn What's New...
  • Method Dev. Challenges
  • Novel Case Studies
  • Emerging Approaches
  • Regulatory Standards
3-DAY Main Workshop
  • No Overlap Parallel Sessions
  • Flexibility to Choose Main Workshop DAYs
7 full-day Specialized Workshops
  • Spread throughout the week
  • Each with an in-depth Focus to maximize your learning process
Personalized Agenda
  • Choose your Main Workshop DAYs
  • Then Combine with Specialized Workshops of your interest
Questions to Regulators
  • Ask them directly to regulators at WRIB
  • Or Submit yours questions before WRIB if you want to be anonymous
Complete Speakers Slides
  • Distributed BEFORE meeting
Poster Awards
  • Free Registration for Next WRIB
  • Interviewed by Bioanalysis Journal
  • Appear in a speical feature report in the Bioanalysis Journal and on Bioanalysis Zone

Agenda in Charts according to your Interest

Agenda Chart for Immunogenicity (ADA) Focus

Monday
Full-Day Specialized Workshop M1:
Immunogenicity Assessment, Harmonization & Clinical Relevance - Latest Advances, Challenges and Solutions from Internationally Recognized Key Opinion Leaders
Tuesday
Main Workshop Day 1:
Ligand-Binding, Cell-Based, and Molecular Assays - Must-Know Breakthroughs, Developments, and Best Practices
Wednesday
Main Workshop Day 2:
2B: Regulators' Advice on Immunogenicity/Technologies of Biotherapeutic, & Gene, Cell & Vaccine Therapies: Regulators’ Inputs & ASK THE REGULATORS - Interactive Panel Discussion with Regulators
Thursday
Full-Day Specialized Workshop Th1:
Ligand-Binding Assays - Latest Advances, Challenges and Solutions from Internationally Recognized Key Opinion Leaders
Friday
Full-Day Specialized Workshop F2:
Gene, Cell, Vaccine Therapies Discovery, Development & Regulatory Approval - Latest Advances, Challenges and Solutions from Internationally Recognized Key Opinion Leaders

Agenda Chart for Biomarker Assay Validation (BAV) Focus

Monday
Full-Day Specialized Workshop M2:
Biomarkers Discovery, Development, Validation & Regulatory Approval - Latest Advances, Challenges and Solutions from Internationally Recognized Key Opinion Leaders
Tuesday
Main Workshop Day 1:
Ligand-Binding, Cell-Based, and Molecular Assays - Must-Know Breakthroughs, Developments, and Best Practices
Wednesday
Main Workshop Day 2:
2A: Regulators' Advice on Bioanalytical Method Validation (BMV) & Biomarkers Assay Validation (BAV): Regulators’ Inputs & ASK THE REGULATORS - Interactive Panel Discussion with Regulators
Thursday
Full-Day Specialized Workshop Th1:
Ligand-Binding Assays - Latest Advances, Challenges and Solutions from Internationally Recognized Key Opinion Leaders
Friday
Full-Day Specialized Workshop F1:
Regulated Bioanalysis Sampling, Validating, Analyzing & Reporting - Latest Advances, Challenges and Solutions from Internationally Recognized Key Opinion Leaders

Agenda Chart for Gene Therapy, Cell Therapy, and Vaccine Focus

Monday
Full-Day Specialized Workshop M2:
Biomarkers Discovery, Development, Validation & Regulatory Approval - Latest Advances, Challenges and Solutions from Internationally Recognized Key Opinion Leaders
Tuesday
Main Workshop Day 1:
Ligand-Binding, Cell-Based, and Molecular Assays - Must-Know Breakthroughs, Developments, and Best Practices
Wednesday
Main Workshop Day 2:
2B: Regulators' Advice on Immunogenicity/Technologies of Biotherapeutic, & Gene, Cell & Vaccine Therapies: Regulators’ Inputs & ASK THE REGULATORS - Interactive Panel Discussion with Regulators
Thursday
Full-Day Specialized Workshop Th2:
Cell-Based Assays - Latest Advances, Challenges and Solutions from Internationally Recognized Key Opinion Leaders
Friday
Full-Day Specialized Workshop F2:
Gene, Cell, Vaccine Therapies Discovery, Development & Regulatory Approval - Latest Advances, Challenges and Solutions from Internationally Recognized Key Opinion Leaders

Agenda Chart for Ligand Binding Assays (LBA) Focus

Monday
Full-Day Specialized Workshop M2:
Biomarkers Discovery, Development, Validation & Regulatory Approval - Latest Advances, Challenges and Solutions from Internationally Recognized Key Opinion Leaders
Tuesday
Main Workshop Day 1:
Ligand-Binding, Cell-Based, and Molecular Assays - Must-Know Breakthroughs, Developments, and Best Practices
Wednesday
Main Workshop Day 2:
2A: Regulators' Advice on Bioanalytical Method Validation (BMV) & Biomarkers Assay Validation (BAV): Regulators’ Inputs & ASK THE REGULATORS - Interactive Panel Discussion with Regulators
2B: Regulators' Advice on Immunogenicity/Technologies of Biotherapeutic, & Gene, Cell & Vaccine Therapies: Regulators’ Inputs & ASK THE REGULATORS - Interactive Panel Discussion with Regulators
Thursday
Full-Day Specialized Workshop Th1:
Ligand-Binding Assays - Latest Advances, Challenges and Solutions from Internationally Recognized Key Opinion Leaders
Friday
Full-Day Specialized Workshop F1:
Regulated Bioanalysis Sampling, Validating, Analyzing & Reporting - Latest Advances, Challenges and Solutions from Internationally Recognized Key Opinion Leaders

Agenda Chart for Cell Based Assays (CBA) Focus

Monday
Full-Day Specialized Workshop M1:
Immunogenicity Assessment, Harmonization & Clinical Relevance - Latest Advances, Challenges and Solutions from Internationally Recognized Key Opinion Leaders
Tuesday
Main Workshop Day 1:
Ligand-Binding, Cell-Based, and Molecular Assays - Must-Know Breakthroughs, Developments, and Best Practices
Wednesday
Main Workshop Day 2:
2B: Regulators' Advice on Immunogenicity/Technologies of Biotherapeutic, & Gene, Cell & Vaccine Therapies: Regulators’ Inputs & ASK THE REGULATORS - Interactive Panel Discussion with Regulators
Thursday
Full-Day Specialized Workshop Th2:
Cell-Based Assays - Latest Advances, Challenges and Solutions from Internationally Recognized Key Opinion Leaders
Friday
Full-Day Specialized Workshop F2:
Gene, Cell, Vaccine Therapies Discovery, Development & Regulatory Approval - Latest Advances, Challenges and Solutions from Internationally Recognized Key Opinion Leaders

Agenda Chart for Mass Spectrometry Assays (MSA) Focus

Monday
Full-Day Specialized Workshop M2:
Biomarkers Discovery, Development, Validation & Regulatory Approval - Latest Advances, Challenges and Solutions from Internationally Recognized Key Opinion Leaders
Tuesday
Full-Day Specialized Workshop T1:
Mass Spectrometry Assays - Latest Advances, Challenges and Solutions from Internationally Recognized Key Opinion Leaders
Wednesday
Main Workshop Day 2:
2A: Regulators' Advice on Bioanalytical Method Validation (BMV) & Biomarkers Assay Validation (BAV): Regulators’ Inputs & ASK THE REGULATORS - Interactive Panel Discussion with Regulators
2B: Regulators' Advice on Immunogenicity/Technologies of Biotherapeutic, & Gene, Cell & Vaccine Therapies: Regulators’ Inputs & ASK THE REGULATORS - Interactive Panel Discussion with Regulators
Thursday
Main Workshop Day 3:
Mass Spectrometry, Chromatography, and Sample Preparation - Must-Know Breakthroughs, Developments, and Best Practices
Friday
Full-Day Specialized Workshop F1:
Regulated Bioanalysis Sampling, Validating, Analyzing & Reporting - Latest Advances, Challenges and Solutions from Internationally Recognized Key Opinion Leaders